By blocking the release of TGF-β1 from UPP1-overexpressing tumor cells using TGF-β1 neutralizing antibodies, we observed a marked decrease in the LAG3 + PDCD1+ exhausted T cell population (Fig. 3f and Supplementary Fig. 9d). The gene discussed is TGFB1; the disease is neoplasm.